Table 1.
Antimicrobial activity of the newly synthesized compounds.
MIC (μg/mL) | |||
---|---|---|---|
Gram Positive bacteria |
Gram Negative bacteria |
||
Compound No. | S. aureus | E. coli | P. aeruginosa |
3 | 12.5 | 50 | 50 |
4 | 25 | 50 | 100 |
5a | 12.5 | 25 | 50 |
5b | 6.25 | 12.5 | 25 |
5c | 12.5 | 25 | 50 |
5d | 25 | 50 | 50 |
5e | 25 | 50 | 50 |
5f | 50 | 100 | 100 |
6 | 12.5 | 25 | 50 |
7 | 25 | 25 | 50 |
8 | 100 | 100 | 100 |
9 | 50 | 50 | 100 |
10 | 6.25 | 25 | 50 |
11 | 6.25 | 12.5 | 50 |
12 | 12.5 | 25 | 100 |
13 | 12.5 | 25 | 50 |
14a | 6.25 | 12.5 | 50 |
14b | 3.125 | 6.25 | 25 |
14c | 6.25 | 12.5 | 25 |
14d | 12.5 | 25 | 50 |
14e | 12.5 | 25 | 50 |
14f | 25 | 50 | 50 |
Ciprofloxacin | 2 | 2 | 4 |